BA.2, the newly detected version of Omicron, is not a cause for alarm

Latest Omicron BA.2 news

A new spinoff of the Omicron variant of the coronavirus is getting attention from scientists as it becomes the dominant cause of Covid-19 infections in some parts of the world.

Experts say there's no reason to panic over the lineage, called BA.2, which was first identified in early December and has since spread to 49 countries including the United States.

"Among all the lineages of Omicron, this is the one showing a higher increase of cases. But we have to be careful in interpreting that because higher increases from a very low number are easier to observe," said Ramon Lorenzo-Redondo, assistant professor of medicine for infectious diseases at Northwestern University Feinberg School of Medicine in Chicago.
Boosters provide the best protection against Omicron variant, CDC studies show, raising new questions about what it means to be fully vaccinated.


Boosters provide the best protection against Omicron variant, CDC studies show, raising new questions about what it means to be fully vaccinated
Like the more familiar version of Omicron, BA.2 has a large number of changes -- about 20 --concentrated in the spike protein, the part of the virus that's targeted by vaccines.
Unlike Omicron, however, it doesn't cause a certain signature on lab tests called an s-gene target failure, meaning it can look like other SARS-CoV-2 variants on a first screen. That has some calling it "the stealth variant."But Lorenzo-Redondo says that nickname has caused people to think that it can't be detected in lab tests, which isn't the case.
"

https://edition.cnn.com/2022/01/27/health/omicron-sublineage-ba2/index.html

Tags : #BA2 #BA2Omicron #Moderna #ModernaOmicronVaccine #BA2

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Uncovering the Presence of Microplastics in Human Blood and Their Health EffectsMay 18, 2024
Potential Risks of Meftal: What Consumers and Doctors Should KnowMay 18, 2024
Over-the-Counter Medications in India: A New Era of AccessibilityMay 18, 2024
DCGI Acts Against Overcharging: New Regulations for Blood CentresMay 17, 2024
Cattle as Hosts for Human and Bird Flu Viruses: A Potential Public Health ConcernMay 17, 2024
The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024